Document Preview Unavailable
Development of an affinity-enhanced clinical candidate TCR targeting NY-ESO-1 with optimal potency and high specificity
Ou, Yusheng; Liu, Ming; Zhan, Kai; Wu, Wanli; Huang, Jiao; et al. bioRxiv, Oct 17, 2022.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library